• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    HWH International Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits

    2/20/25 9:00:05 AM ET
    $HWH
    Other Pharmaceuticals
    Health Care
    Get the next $HWH alert in real time by email
    false --12-31 0001897245 0001897245 2025-02-18 2025-02-18 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT

    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

     

    Date of Report (Date of earliest event reported): February 18, 2025

     

    HWH International Inc.

    (Exact name of registrant as specified in its charter)

     

    Delaware   001-41254   87-3296100

    (State or other jurisdiction

    of incorporation)

     

    (Commission

    File Number)

     

    (I.R.S. Employer

    Identification No.)

     

    4800 Montgomery Lane, Suite 210 Bethesda, MD   20814
    (Address of principal executive offices)   (Zip Code)

     

    Registrant’s telephone number, including area code: (301) 971-3955

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions (see General Instruction A.2. below):

     

    ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
       
    ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
       
    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
       
    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class   Trading Symbol(s)   Name of each exchange on which registered
    Common Stock, $0.0001 par value per share   HWH   The Nasdaq Capital Market

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

    Emerging growth company ☒

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     

     

     

     

    Item 3.03. Material Modification to Rights of Security Holders.

     

    The information set forth in Item 5.03 of this Current Report on Form 8-K is incorporated by reference into Item 3.03 of this Current Report on Form 8-K.

     

    Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

     

    On February 18, 2025, HWH International Inc., a Delaware corporation (the “Company”), filed a Certificate of Amendment to the Company’s Amended and Restated Certificate of Incorporation with the Delaware Secretary of State to effect a 1-for-5 reverse stock split (the “Reverse Stock Split”). The Reverse Stock Split will be effective as of market open on February 24, 2025 (the “Effective Time”).

     

    At the Effective Time, each 5 shares of the Company’s common stock issued and outstanding will be combined and converted into 1 share of the Company’s common stock. The par value of the common stock following the Reverse Stock Split will remain at $0.0001 per share. No fractional shares shall be issued as a result of the Reverse Stock Split. In lieu thereof, any person who would otherwise be entitled to a fractional share of common stock as a result of the Reverse Stock Split will be entitled to receive a cash payment equal to the fraction of a share of common stock to which such holder would otherwise be entitled multiplied by the closing price per share of the common stock on the Nasdaq Capital Market on the date of the effectiveness of the reverse stock split.

     

    In connection with the Reverse Stock Split, the CUSIP number for the common stock will be changed to 44852G309.

     

    Item 8.01. Other Information.

     

    On February 20, 2025, the Company issued a press release announcing an anticipated effective date of February 24, 2025 for the Reverse Stock Split. A copy of the press release is attached as Exhibit 99.1 hereto and incorporated herein by reference.

     

    Item 9.01 Financial Statements and Exhibits.

     

    (d) Exhibits

     

    Exhibit

    Number

      Description
         
    3.1   Amendment to Amended and Restated Certificate of Incorporation.
    99.1  

    Press Release dated February 20, 2025

    104   Cover page Interactive Data File (embedded within the Inline XBRL document).

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Date: February 20, 2025 HWH INTERNATIONAL INC.
         
      By: /s/ Rongguo Wei
      Name: Rongguo Wei
      Title: Chief Financial Officer

     

     

     

    Get the next $HWH alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $HWH

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $HWH
    Financials

    Live finance-specific insights

    See more
    • HWH International Inc. Acquires Café in South Korea, Unveiling Second Hapi Cafe Outlet

      Bethesda, MD, Feb. 26, 2024 (GLOBE NEWSWIRE) -- HWH International Inc. ("HWH") (NASDAQ:HWH) proudly announces the acquisition of a café in Seocho-gu, South Korea, marking the launch of its second Hapi Cafe outlet in South Korea. HWH is delighted to reveal its latest acquisition of a café nestled in the heart of Seocho-gu, South Korea. This strategic move signifies HWH's dedication to providing unique and welcoming spaces where people can gather to savor food, coffee, and experiences. These cafes are a significant driver of our Health, Wealth, and Happiness vision to offer delicious and nutritious food and beverages to our customers and provide a platform where we can roll out lifestyle pr

      2/26/24 4:15:00 PM ET
      $HWH
      Other Pharmaceuticals
      Health Care

    $HWH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Chan Heng Fai Ambrose bought $585,000 worth of shares (1,300,000 units at $0.45) (SEC Form 4)

      4 - HWH International Inc. (0001897245) (Issuer)

      12/26/24 5:15:05 PM ET
      $HWH
      Other Pharmaceuticals
      Health Care
    • Director Chan Heng Fai Ambrose bought $3,000,000 worth of shares (4,411,764 units at $0.68) (SEC Form 4)

      4 - HWH International Inc. (0001897245) (Issuer)

      11/26/24 7:12:12 PM ET
      $HWH
      Other Pharmaceuticals
      Health Care
    • Chief Executive Officer Chan Heng Fai Ambrose bought $3,801,758 worth of shares (6,034,537 units at $0.63) (SEC Form 4)

      4 - HWH International Inc. (0001897245) (Issuer)

      9/26/24 9:39:51 PM ET
      $HWH
      Other Pharmaceuticals
      Health Care

    $HWH
    SEC Filings

    See more
    • SEC Form 10-Q filed by HWH International Inc.

      10-Q - HWH International Inc. (0001897245) (Filer)

      5/15/25 4:16:04 PM ET
      $HWH
      Other Pharmaceuticals
      Health Care
    • SEC Form SCHEDULE 13G filed by HWH International Inc.

      SCHEDULE 13G - HWH International Inc. (0001897245) (Subject)

      5/14/25 4:42:18 PM ET
      $HWH
      Other Pharmaceuticals
      Health Care
    • SEC Form 10-K filed by HWH International Inc.

      10-K - HWH International Inc. (0001897245) (Filer)

      3/31/25 4:05:57 PM ET
      $HWH
      Other Pharmaceuticals
      Health Care

    $HWH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Executive Chairman Chan Heng Fai Ambrose

      4 - HWH International Inc. (0001897245) (Reporting)

      4/2/25 8:37:43 PM ET
      $HWH
      Other Pharmaceuticals
      Health Care
    • Director Chan Heng Fai Ambrose acquired 69,444 shares (SEC Form 4)

      4 - HWH International Inc. (0001897245) (Issuer)

      3/13/25 4:15:07 PM ET
      $HWH
      Other Pharmaceuticals
      Health Care
    • SEC Form 4 filed by Executive Chairman Chan Heng Fai Ambrose

      4 - HWH International Inc. (0001897245) (Reporting)

      1/28/25 9:36:07 PM ET
      $HWH
      Other Pharmaceuticals
      Health Care

    $HWH
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • HWH International Inc. Announces Reverse Stock Split

      BETHESDA, MD, Feb. 20, 2025 (GLOBE NEWSWIRE) -- HWH International Inc. (the "Company") (NASDAQ:HWH), a purpose-driven lifestyle company, today announced a 1-for-5 reverse stock split of the Company's common stock to become effective at 9:00 a.m. (Eastern Time) on February 24, 2025. The Company's common stock is expected to begin trading on a split-adjusted basis when the markets open on February 24, 2025, under the existing trading symbol "HWH." The reverse stock split is primarily intended to bring the Company into compliance with the minimum bid price requirements for maintaining its listing on the Nasdaq Capital Market. The new CUSIP number following the reverse stock split will be 448

      2/20/25 8:50:00 AM ET
      $HWH
      Other Pharmaceuticals
      Health Care
    • D. Boral Capital Served as Placement Agent to HWH International Inc. (Nasdaq: HWH) in connection with its approximately $1.76 Million Public Offering

      BETHESDA, Md., Jan. 07, 2025 (GLOBE NEWSWIRE) -- HWH International Inc. (the "Company") (NASDAQ:HWH), a purpose-driven lifestyle company, today announced the closing of its public offering (the "Offering") with aggregate gross proceeds to the Company of $1,764,900, prior to deducting fees and other expenses payable by the Company. The Offering consisted of 3,412,500 shares of common stock and 1,000,000 pre-funded warrants to purchase 1,000,000 shares of common stock. Each share of common stock (or pre-funded warrant in lieu thereof) was sold at a purchase price of $0.40 per share (or $0.3999 per pre-funded warrant after reducing $0.0001 attributable to the exercise price of the pre-funded

      1/7/25 11:18:56 AM ET
      $HWH
      Other Pharmaceuticals
      Health Care
    • HWH International Inc. Announces Closing of Approximately $1.76 Million Public Offering at $0.40 per Share

      BETHESDA, MD, Jan. 06, 2025 (GLOBE NEWSWIRE) -- HWH International Inc. (the "Company") (NASDAQ:HWH), a purpose-driven lifestyle company, today announced the closing of its public offering (the "Offering") with aggregate gross proceeds to the Company of $1,764,875, prior to deducting fees and other expenses payable by the Company. The Offering consisted of 3,125,000 shares of common stock and 1,250,000 pre-funded warrants to purchase 1,250,000 shares of common stock. Each share of common stock (or pre-funded warrant in lieu thereof) was sold at a purchase price of $0.40 per share (or $0.3999 per pre-funded warrant after reducing $0.0001 attributable to the exercise price of the pre-funded w

      1/6/25 4:20:00 PM ET
      $HWH
      Other Pharmaceuticals
      Health Care

    $HWH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13D/A filed by HWH International Inc.

      SC 13D/A - HWH International Inc. (0001897245) (Subject)

      11/26/24 7:34:11 PM ET
      $HWH
      Other Pharmaceuticals
      Health Care
    • Amendment: SEC Form SC 13D/A filed by HWH International Inc.

      SC 13D/A - HWH International Inc. (0001897245) (Subject)

      11/22/24 5:00:10 PM ET
      $HWH
      Other Pharmaceuticals
      Health Care
    • Amendment: SEC Form SC 13G/A filed by HWH International Inc.

      SC 13G/A - HWH International Inc. (0001897245) (Subject)

      11/14/24 12:40:52 PM ET
      $HWH
      Other Pharmaceuticals
      Health Care